Table of Contents Author Guidelines Submit a Manuscript
International Journal of Chronic Diseases
Volume 2014, Article ID 201423, 7 pages
http://dx.doi.org/10.1155/2014/201423
Research Article

Microvascular Complications and Their Associated Risk Factors in Newly Diagnosed Type 2 Diabetes Mellitus Patients

1Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Mohali 160062, India
2Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh 160062, India

Received 18 July 2014; Revised 12 November 2014; Accepted 13 November 2014; Published 30 November 2014

Academic Editor: Jens Klotsche

Copyright © 2014 Dipika Bansal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, “Global estimates of diabetes prevalence for 2013 and projections for 2035,” Diabetes Research and Clinical Practice, vol. 103, pp. 137–149, 2013. View at Google Scholar
  2. M. I. Harris, R. Klein, T. A. Welborn, and M. W. Knuiman, “Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis,” Diabetes Care, vol. 15, no. 7, pp. 815–819, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Margolis, “Diabetic microvascular complications: an overview,” Advanced Studies in Medicine, vol. 5, no. 4, pp. S260–S263, 2005. View at Google Scholar · View at Scopus
  4. N. Agarwal, N. S. Sengar, P. K. Jain, and R. Khare, “Nephropathy in newly diagnosed type 2 diabetics with special stress on the role of hypertension,” Journal of Association of Physicians of India, vol. 59, no. 3, pp. 145–147, 2011. View at Google Scholar · View at Scopus
  5. American Association of Diabetes, “Executive summary: standards of medical care in diabetes-2013,” Diabetes Care, vol. 36, pp. S4–S10, 2013. View at Google Scholar
  6. M. Bairwa, M. Rajput, and S. Sachdeva, “Modified kuppuswamy’s socioeconomic scale: social researcher should include updated income criteria, 2012,” Indian Journal of Community Medicine, vol. 38, no. 3, pp. 185–186, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Bansal, K. Gudala, H. Muthyala, H. P. Esam, R. Nayakallu, and A. Bhansali, “Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting,” Journal of Diabetes Investigation, vol. 5, no. 6, pp. 714–721, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Viswanath and D. D. McGavin, “Diabetic retinopathy: clinical findings and management,” Community Eye Health, vol. 16, no. 46, pp. 21–24, 2003. View at Google Scholar · View at Scopus
  9. T. Zelmanovitz, F. Gerchman, A. P. Balthazar, F. C. Thomazelli, J. D. Matos, and L. H. Canani, “Diabetic nephropathy,” Diabetology & Metabolic Syndrome, vol. 1, article 10, 2009. View at Publisher · View at Google Scholar
  10. T. A. Samuels, D. Cohen, F. L. Brancati, J. Coresh, and W. H. L. Kao, “Delayed diagnosis of incident type 2 diabetes mellitus in the ARIC study,” American Journal of Managed Care, vol. 12, no. 12, pp. 717–724, 2006. View at Google Scholar · View at Scopus
  11. R. Raman, A. Gupta, S. Krishna, V. Kulothungan, and T. Sharma, “Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN DREAMS, report 27),” Journal of Diabetes and its Complications, vol. 26, no. 2, pp. 123–128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Patel, A. Shingare, G. Kalita, and V. Bhandari, “Clinical study of microvascular complications in newly diagnosed diabetes mellitus patients,” Indian Journal of Applied Research, vol. 4, pp. 12–14, 2014. View at Google Scholar
  13. A. Dutta, S. Naorem, T. P. Singh, and K. Wangjam, “Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics,” International Journal of Diabetes in Developing Countries, vol. 25, pp. 30–33, 2005. View at Google Scholar
  14. A. Sosale, K. M. P. Kumar, S. M. Sadikot et al., “Chronic complications in newly diagnosed patients with type 2 diabetes mellitus in India,” Indian Journal of Endocrinology and Metabolism, vol. 18, no. 3, pp. 355–360, 2014. View at Google Scholar
  15. M. S. Azura, H. I. Adibah, and S. Juwita, “Risk factor of peripheral neuropathy among newly diagnosed type 2 diabetic patients in primary care clinic,” International Journal of Collaborative Research on Internal Medicine and Public Health, vol. 4, no. 11, pp. 1858–1867, 2012. View at Google Scholar · View at Scopus
  16. N. de Fine Olivarius, N. V. Nielsen, and A. H. Andreasen, “Diabetic retinopathy in newly diagnosed middle-aged and elderly diabetic patients. Prevalence and interrelationship with microalbuminuria and triglycerides,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 239, no. 9, pp. 664–672, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. M. H. Khazai, B. Khazai, Z. Zargaran, Z. Moosavi, and F. K. Zand, “Diabetic complications and risk factors in recently diagnosed type 2 diabetes: a case control study,” ARYA Atheroscler, vol. 2, pp. 79–83, 2006. View at Google Scholar
  18. F. J. Del Canizo Gomez, C. Fernandez Perez, I. Moreno Ruiz et al., “Microvascular complications and risk factors in patients with type 2 diabetes,” Endocrinología y Nutrición, vol. 58, pp. 163–168, 2011. View at Publisher · View at Google Scholar
  19. P. E. Wändell, “Risk factors for microvascular and macrovascular complications in men and women with type 2 diabetes,” Scandinavian Journal of Primary Health Care, vol. 17, no. 2, pp. 116–121, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Ashok, M. Ramu, R. Deepa, and V. Mohan, “Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India,” Journal of Association of Physicians of India, vol. 50, no. 4, pp. 546–550, 2002. View at Google Scholar · View at Scopus
  21. H. K. Kumar, S. K. Kota, A. Basile, and K. Modi, “Profile of microvascular disease in type 2 diabetes in a tertiary care hospital in India,” Annals of Medical and Health Sciences Research, vol. 2, pp. 103–108, 2012. View at Google Scholar
  22. T. D. Wiggin, K. A. Sullivan, R. Pop-Busui, A. Amato, A. A. F. Sima, and E. L. Feldman, “Elevated triglycerides correlate with progression of diabetic neuropathy,” Diabetes, vol. 58, no. 7, pp. 1634–1640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. N. K. Subbalaxmi, K. N. S. Rao, P. M. R. Adhikari, and S. R. Pai, “Influence of dyslipidemia on somatic neuropathy in type 2 diabetes mellitus,” Nitte University Journal of Health Science, vol. 3, pp. 25–30, 2013. View at Google Scholar
  24. R. Shankar, M. Shashikiram, M. Gopalraj, and E. N. Ratnabai, “Assessment of serum triglycerides among diabetic patients with peripheral neuropathy,” Journal of Medical Research and Practice, vol. 1, pp. 68–72, 2012. View at Google Scholar
  25. M. Mociran, C. Kragose, and N. Hancu, “Risk factors and diabetic retinopathy in maramures,” Applied Medical Informatics, vol. 24, pp. 47–52, 2009. View at Google Scholar
  26. A. M. Abu El-Asrar, K. A. Al-Rubeaan, S. A. Al-Amro, O. A. Moharram, and D. Kangave, “Retinopathy as a predictor of other diabetic complications,” International Ophthalmology, vol. 24, no. 1, pp. 1–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Al-Rubeaan, A. M. Youssef, S. N. Subhani et al., “Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi national diabetes registry-based study,” PLoS ONE, vol. 9, no. 2, Article ID e88956, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. M. da Silva Correa, A. M. Freitas, and I. M. Marcon, “Risk factors related to the severity of diabetic retionopathy,” Arquivos Brasileiros de Oftalmologia, vol. 66, pp. 739–743, 2003. View at Google Scholar
  29. A. H. Alrawahi, S. G. A. Rizvi, D. Al-Riami, and Z. Al-Anqoodi, “Prevalence and risk factors of diabetic nephropathy in Omani type 2 diabetics in Al-Dakhiliyah region,” Oman Medical Journal, vol. 27, no. 3, pp. 212–216, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Maric and S. Sullivan, “Estrogens and the diabetic kidney,” Gender Medicine, vol. 5, no. 1, pp. S103–S113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Manzato, S. Zambon, A. Cortella, G. Sartore, R. Nosadini, and G. Crepaldi, “Lipids and diabetic nephropathy: hypertension, microalbuminuria and lipids in type 2 diabetic patients,” Acta Diabetologica, vol. 29, no. 3-4, pp. 231–233, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. F. C. Shen, C. Y. Chen, S. C. Su, and R. T. Liu, “The prevalence and risk factors of diabetic nephropathy in taiwanese type 2 diabetes a hospital based study,” Acta Nephrolagica, vol. 23, pp. 90–127, 2009. View at Google Scholar
  33. M. Iranparvar Alamdari, N. Aminisani, B. Bhashardoost et al., “Prevalence and risk factors of microalbuminuria in type 2 diabetic patients in a diabetic clinic of Ardabil-Iran,” International Journal of Endocrinology and Metabolism, vol. 4, pp. 8–12, 2006. View at Google Scholar
  34. J. C. Rutledge, K. F. Ng, H. H. Aung, and D. W. Wilson, “Role of triglyceride-rich lipoproteins in diabetic nephropathy,” Nature Reviews Nephrology, vol. 6, no. 6, pp. 361–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Raz, “Guideline approach to therapy in patients with newly diagnosed type 2 diabetes,” Diabetes Care, vol. 36, no. 2, pp. S139–S144, 2013. View at Publisher · View at Google Scholar · View at Scopus